2018
DOI: 10.4070/kcj.2018.0074
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of Femoropopliteal Artery In-stent Restenosis

Abstract: Femoropopliteal (FP) artery-in stent restenosis (ISR) is a daunting management problem that we continue to face. FP artery-ISR rates after primary stent implantation are relatively high. Although repeat FP artery-ISR and the need for additional interventions remain all too common, little consensus exists regarding the best treatment algorithm. In this article, we review the limitations of the currently used devices for the endovascular treatment of FP artery-ISR and discuss which strategies are the most effect… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
8
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(9 citation statements)
references
References 29 publications
(27 reference statements)
1
8
0
Order By: Relevance
“…This finding is consistent with the observation that the largest lumen remodeling in SFAs occurs at 1Y post-intervention. 19 Overall, similar results were found by analyzing the ISR progression of both the entire lesions and segments of the lesions. Specifically, the lumen remodeling trajectory (i.e.…”
Section: Morphological Progressionsupporting
confidence: 79%
See 2 more Smart Citations
“…This finding is consistent with the observation that the largest lumen remodeling in SFAs occurs at 1Y post-intervention. 19 Overall, similar results were found by analyzing the ISR progression of both the entire lesions and segments of the lesions. Specifically, the lumen remodeling trajectory (i.e.…”
Section: Morphological Progressionsupporting
confidence: 79%
“…This finding is consistent with the observation that the largest lumen remodeling in SFAs occurs at 1Y post-intervention. 19 …”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…However, major concerns about the durability of this outcome have been raised, specifically regarding the mid- and long-term in-stent restenosis (ISR) and stent fracture 12 14 . Indeed, at the same time, it is estimated that about 30% to 40% of stented patients will require repeated revascularization (usually surgical) at the same lesion site 13 , following vessel re-occlusion within 12 months 15 , with an ISR peak occurring between 9 and 15 months after the endovascular procedure 16 . Furthermore, it was reported that, after 2 years, the occurrence of ISR in SFA is reduced and the lesions seem more related to the evolution of atheromatous disease rather than neointimal hyperplasia 17 , 18 .…”
Section: Introductionmentioning
confidence: 99%
“…Bare metal stents implantation is commonly used. Stents resolve the problems of elastic recoil, residual stenosis and dissection but ISR stay high with an incidence of 15% to 32% in 12 months (3,9). Dick et al showed the ISR treatment with angioplasty resulted in a restenosis recurrence rate with up to 73% (10).…”
Section: Resultsmentioning
confidence: 99%